Fenbendazole (methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate) is a commonly used anthelmintic medicine to treat parasitic worm infections in animals. However, multiple peer-reviewed scientific journal papers have shown that fenbendazole and other drugs in the benzimidazole family also possess cancer fighting properties that could make them effective for treating and even curing some forms of deadly malignancies in humans.
These studies have demonstrated that fenbendazole and similar benzimidazole medications can suppress the growth of tumors by inhibiting their cell cycle progression and causing their apoptosis. One study in particular found that fenbendazole and many other drugs in this class can reactivate the p53 gene inside cancer cells, thereby triggering apoptosis and preventing the spread of tumors.
The results of these experiments have been replicated by several other researchers, indicating that fenbendazole and several other benzimidazole medicines can successfully cure or prevent the recurrence of certain forms of deadly cancers in humans. As a result, there are now a growing number of websites and social media pages that display the stories of people who have used fenbendazole for cancer along with other treatments to overcome their illnesses.
Although fenbendazole is known to be safe for short-term use in most animals, the safety and effectiveness of long exposure has not yet been scientifically documented. This is likely because fenbendazole’s ability to eradicate parasitic worm infections usually only takes a few weeks at most. Nonetheless, many people have chosen to ignore the lack of scientific data and continue to take fenbendazole for cancer or to prevent recurrence of their diseases on their own. fenbendazole for humans